|
| 总计 | TACE | TACE+HAIC | p Value |
| N = 156 | N = 76 | N = 80 | ||
| 性别 |
|
|
| 0.148 |
| 男 | 133 (85.3%) | 68 (89.5%) | 65 (81.3%) | |
| 女 | 23 (14.7%) | 8 (10.5%) | 15 (18.7%) | |
| 年龄 | 54.3 (29~84) | 55.6 (29~84) | 53.0 (29~71) | 0.128 |
| BCLC |
|
|
| 0.075 |
| A | 18 (11.5%) | 12 (15.8%) | 6 (7.5%) | |
| B | 74 (47.4%) | 39 (51.3%) | 35 (43.8%) | |
| C | 64 (41.1%) | 25 (32.9%) | 39 (48.8%) | |
| ChildPugh |
|
|
| 0.720 |
| A | 148 (94.9%) | 73 (96.1%) | 75 (93.8%) | |
| B | 8 (5.1%) | 3 (3.9%) | 5 (6.3) | |
| 免疫 |
|
|
| 0.588 |
| 是 | 65 (41.7%) | 30 (39.5%) | 35 (43.8%) | |
| 否 | 91 (58.3%) | 46 (60.5%) | 45 (56.3%) | |
| CauseHCC |
|
|
| 0.931 |
| 其他 | 23 (14.7%) | 12 (15.8%) | 11 (13.8%) | |
| HBV | 130 (83.3%) | 63 (82.9%) | 67 (83.8%) | |
| HCV | 3 (1.9%) | 1 (1.3%) | 2 (2.5%) | |
| 肝硬化 |
|
|
| 0.182 |
| 无 | 27 (17.3%) | 10 (13.2%) | 17 (21.3%) | |
| 有 | 129 (82.7%) | 66 (86.8%) | 63 (78.8%) | |
| 肿瘤数目 |
|
|
| 0.190 |
| 单发 | 84 (53.8%) | 45 (59.2%) | 39 (48.8%) | |
| 多发 | 72 (46.2%) | 31 (30.8%) | 41 (51.2%) | |
| 血管受侵 |
|
|
| 0.405 |
| 否 | 85 (54.5%) | 44 (57.9%) | 41 (51.3%) | |
| 是 | 71 (45.5%) | 32 (42.1%) | 39 (48.8%) | |
| AFP |
|
|
| 0.147 |
| <1000 | 102 (65.4%) | 54 (71.1%) | 48 (60.0%) | |
| ≥1000 | 54 (34.6%) | 22 (28.9%) | 32 (40.0%) | |
| 治疗次数 | 2.17 | 2.29 | 2.06 | 0.174 |